<!DOCTYPE html>
<html lang="en"><head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1" name="viewport"/>
<link href="https://cdn-icons-png.flaticon.com/512/4021/4021693.png" rel="icon"/>
<link href="../style.css" rel="stylesheet"/>
<link href="https://fonts.googleapis.com" rel="preconnect"/>
<link crossorigin="" href="https://fonts.gstatic.com" rel="preconnect"/>
<link href="https://fonts.googleapis.com/css2?family=Inter:wght@300;400;500;600&amp;family=Space+Mono:wght@400;700&amp;display=swap" rel="stylesheet"/>
<title>PRL-8-53</title>
</head><body><main class="container"><header class="site-header">
<h1 class="logo"><a href="../index.html">r/anhedonia</a></h1>
<p class="subtitle">Personal Wiki</p>
</header><nav style="margin-bottom: 20px;"><a href="../actions.html">← Back to Personal Wiki</a></nav><section class="card"><h2>PRL-8-53</h2><ul>
<li><img src="https://upload.wikimedia.org/wikipedia/commons/thumb/7/79/PRL-8-53.svg/220px-PRL-8-53.svg.png"/></li>
<li>Cholinergic</li>
<li>Potentiates dopamine.</li>
<li>Partially inhibiting serotonin.</li>
<li>PRL-8-53 reverses the catatonic and ptotic effects of reserpine.</li>
<li>Oral LD50 in mice of 860 mg/kg</li>
<li>Doses above 8 mg/kg have brief hypotensive effects in canines.</li>
<li>High doses depress motor activity in the rat and mouse, with the ED50 for a 50% reduction in motor activity of mice at 160 mg/kg.</li>
<li>PRL-8-53 displays spasmolytic effects.</li>
</ul></section><footer class="site-footer">
<p><a href="../index.html">← Back to Home</a></p>
</footer></main><script src="../js/router.js"></script></body></html>